CONTRAST-INDUCED NEPHROPATHY
Clinical trials for CONTRAST-INDUCED NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new CONTRAST-INDUCED NEPHROPATHY trials appear
Sign up with your email to follow new studies for CONTRAST-INDUCED NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a common blood pressure pill shield diabetic kidneys from contrast dye?
Disease control Not yet recruitingThis early-phase study tests whether a low dose of oral amlodipine can prevent kidney damage caused by contrast dye in diabetic patients in the intensive care unit. The trial will enroll 40 adults with diabetes and normal kidney function who are stable enough for the procedure. R…
Matched conditions: CONTRAST-INDUCED NEPHROPATHY
Phase: EARLY_PHASE1 • Sponsor: Minia University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could your electrolytes predict kidney damage after a stroke procedure?
Knowledge-focused Not yet recruitingThis study examines whether blood electrolyte levels are linked to kidney damage in people who have a stroke and undergo a clot-removal procedure. Researchers will review medical records from 250 patients treated between 2018 and 2026. The goal is to identify risk factors that co…
Matched conditions: CONTRAST-INDUCED NEPHROPATHY
Sponsor: Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC